Mechanochemical Reaction of Sulfathiazole with Carboxylic Acids: Formation of a Cocrystal, a Salt, and Coamorphous Solids

The anhydrous solvent-free mechanochemical reaction of sulfathiazole, STZ, polymorphs I, III, and V with 10 carboxylic acids was monitored by powder X-ray diffraction (PXRD), attenuated total reflectance infrared (ATR-IR), and near-infrared (NIR) spectroscopy. A 1:1 cocrystal was observed with glutaric acid and the strongest acid, oxalic acid, gave a 1:1 salt. A principal components analysis of the glutaric acid NIR data showed that forms I and V proceeded to the cocrystal, but that form III transformed to form IV before cocrystal formation. The oxalic acid salt was formed via complete amorphization. The crystal structures of the cocrystal and the salt were determined. Sulfathiazole comilled with l-tartaric and citric acids gave coamorphous systems that were stable at 10% RH for up to 28 days. Comilling sulfathiazole with dl-malic acid gave mixtures of form V and the amorphous form.

[1]  J. Mcintosh,et al.  ACRIDINE-SULPHONAMIDE COMPOUNDS AS WOUND ANTISEPTICS CLINICAL TRIALS OF FLAVAZOLE , 1945 .

[2]  Origin of Two Modes of Non-isothermal Crystallization of Glasses Produced by Milling , 2012, Pharmaceutical Research.

[3]  H. Brittain.  Polymorphism and solvatomorphism 2010. , 2012, Journal of pharmaceutical sciences.

[4]  D. Braga,et al.  Solvent effect in a “solvent free” reaction , 2007 .

[5]  M. Caira.  Sulfa drugs as model cocrystal formers. , 2007, Molecular pharmaceutics.

[6]  Po-Chun Hsu,et al.  A portable fiber-optic Raman analyzer for fast real-time screening and identifying cocrystal formation of drug-coformer via grinding process , 2013 .

[7]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[8]  Raj Suryanarayanan,et al.  A rapid thermal method for cocrystal screening , 2008 .

[9]  An investigation into water interactions with amorphous and milled salbutamol sulphate: the development of predictive models for uptake and recrystallization. , 2012, International journal of pharmaceutics.

[10]  D. Braga,et al.  Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks. , 2006, Dalton transactions.

[11]  H. Brittain.  Pharmaceutical cocrystals: the coming wave of new drug substances. , 2013, Journal of pharmaceutical sciences.

[12]  W. Schlindwein,et al.  Pharmaceutical cocrystals: an overview. , 2011, International journal of pharmaceutics.

[13]  R. S. Payne,et al.  Crystal chemistry and solvent effects in polymorphic systems Sulfathiazole , 1998 .

[14]  N. Rodríguez-Hornedo,et al.  Pharmaceutical cocrystals and poorly soluble drugs. , 2013, International journal of pharmaceutics.

[15]  Chiachung Chen,et al.  Uncertainty evaluation of humidity sensors calibrated by saturated salt solutions , 2007 .

[16]  P. McArdle.  SORTX - a program for on-screen stick-model editing and autosorting of SHELX files for use on a PC , 1995 .

[17]  Bernard Van Eerdenbrugh,et al.  Application of mid-IR spectroscopy for the characterization of pharmaceutical systems. , 2011, International journal of pharmaceutics.

[18]  Y. Ikeda,et al.  Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals. , 2012, International journal of pharmaceutics.

[19]  E. Boldyreva,et al.  The effect of carboxylic acids on glycine polymorphism, salt and co-crystal formation. A comparison of different crystallisation techniques , 2013 .

[20]  S. Tavener,et al.  Sulfathiazole polymorphism studied by magic-angle spinning NMR. , 1999, Journal of pharmaceutical sciences.

[21]  W. Jones,et al.  Screening for crystalline salts via mechanochemistry. , 2006, Chemical communications.

[22]  T. Rades,et al.  Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  C. Strachan,et al.  Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. , 2011, Molecular pharmaceutics.

[24]  William Jones,et al.  Achieving Polymorphic and Stoichiometric Diversity in Cocrystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding , 2005 .

[25]  Michael B. Hursthouse,et al.  Packing similarity in polymorphs of sulfathiazole , 2008 .

[26]  F. Allen.  The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.

[27]  N. Trasi,et al.  Mechanically Induced Amorphization of Drugs: A Study of the Thermal Behavior of Cryomilled Compounds , 2012, AAPS PharmSciTech.

[28]  Y. Yoshihashi,et al.  Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. , 2012, International journal of pharmaceutics.

[29]  Mary F. Mahon,et al.  A method for the prediction of the crystal structure of ionic organic compounds—the crystal structures of o-toluidinium chloride and bromide and polymorphism of bicifadine hydrochloride , 2004 .

[30]  Z. Nagy,et al.  Investigation of the riddle of sulfathiazole polymorphism. , 2011, International journal of pharmaceutics.

[31]  C. Strachan,et al.  Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  P. McArdle,et al.  Predicting and understanding crystal morphology: the morphology of benzoic acid and the polymorphs of sulfathiazole , 2010 .

[33]  T. Rades,et al.  Formation Kinetics and Stability of Carbamazepine―Nicotinamide Cocrystals Prepared by Mechanical Activation , 2009 .

[34]  Cheng-Hung Hsu,et al.  Solid-state transformation of different gabapentin polymorphs upon milling and co-milling. , 2010, International journal of pharmaceutics.

[35]  Michael B. Hursthouse,et al.  Over one hundred solvates of sulfathiazole , 2001 .

[36]  B. K. Hodnett,et al.  Relative Stabilities of the Five Polymorphs of Sulfathiazole , 2012 .

[37]  Margaret C. Etter,et al.  Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .

[38]  V. Caron,et al.  Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling. , 2013, Molecular pharmaceutics.

[39]  Mark S. Gordon,et al.  General atomic and molecular electronic structure system , 1993, J. Comput. Chem..

[40]  J. Anwar,et al.  Polymorphism of sulfathiazole. , 1989, Journal of pharmaceutical sciences.

[41]  S. Chan,et al.  Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives. , 2010, Journal of pharmaceutical sciences.

[42]  Alan G. Ryder,et al.  Solid-state transformations of sulfathiazole polymorphs: The effects of milling and humidity , 2013 .

[43]  A. Erxleben,et al.  Supramolecular Structures and Tautomerism of Carboxylate Salts of Adenine and Pharmaceutically Relevant N6-Substituted Adenine , 2011 .

[44]  Å. Rasmuson,et al.  Thermodynamics and Crystallization of the Theophylline–Glutaric Acid Cocrystal , 2013 .

[45]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.